Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details

v3.20.2
Condensed Consolidated Financial Statements Details
6 Months Ended
Jun. 30, 2020
Condensed Consolidated Financial Statements Details  
Condensed Consolidated Financial Statements Details

3. Condensed Consolidated Financial Statements Details

Equity Securities

As of June 30, 2020 and December 31, 2019, equity securities consisted of an investment in Rezolute’s common stock of $0.5 million and $0.7 million, respectively (Note 4). For the three and six months ended June 30, 2020 the Company recognized a gain of $0.1 million and a loss of $0.2 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive loss, and the Company recognized $31,000 and $0.7 million in gains for the three and six months ended June 30, 2019.

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

June 30, 

December 31, 

    

2020

    

2019

Accrued legal and accounting fees

$

378

$

256

Accrued payroll and other benefits

 

119

 

231

Interest payable

 

56

 

69

Accrued incentive compensation

 

24

 

332

Other

 

28

 

57

Total

$

605

$

945

Net Loss Per Share Attributable to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2020

    

2019

    

2020

    

2019

Numerator

 

  

 

  

 

  

 

  

Net loss available to common stockholders

$

(3,533)

$

(4,072)

$

(8,291)

$

(839)

 

 

 

 

Denominator

 

 

 

 

Weighted average shares used in computing basic and diluted net loss per share available to common stockholders

 

10,824

 

8,725

 

10,292

 

8,716

Basic and diluted net loss per share of common stock

$

(0.33)

$

(0.47)

$

(0.81)

$

(0.10)

Potentially dilutive securities are excluded from the calculation of diluted net loss per share available to common stockholders if their inclusion is anti-dilutive.

The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2020

    

2019

    

2020

    

2019

Convertible preferred stock

 

5,196

 

6,256

 

5,726

 

6,256

Common stock options

 

564

 

1,934

 

578

 

1,861

Warrants for common stock

 

19

 

28

 

19

 

27

Total

 

5,779

 

8,218

 

6,323

 

8,144